Project Details
Description
An Open-Label Phase I/II Dose Finding Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Striatal Administration of BV-101 in Adult Subjects with Early Manifest Huntington?s Disease (HD), ASK-HD-01-CS-101
| Status | Active |
|---|---|
| Effective start/end date | 3/1/22 → 8/31/25 |
Funding
- ASKLEPIOS BIOPHARMACEUTICAL, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.